Bio-Techne (BSP:T1CH34) Gross Margin % : 64.78% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Bio-Techne Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Bio-Techne's Gross Profit for the three months ended in Dec. 2023 was R$865 Mil. Bio-Techne's Revenue for the three months ended in Dec. 2023 was R$1,336 Mil. Therefore, Bio-Techne's Gross Margin % for the quarter that ended in Dec. 2023 was 64.78%.

The historical rank and industry rank for Bio-Techne's Gross Margin % or its related term are showing as below:

BSP:T1CH34' s Gross Margin % Range Over the Past 10 Years
Min: 65.41 Med: 67.59 Max: 70.27
Current: 67.13

During the past 13 years, the highest Gross Margin % of Bio-Techne was 70.27%. The lowest was 65.41%. And the median was 67.59%.

BSP:T1CH34's Gross Margin % is ranked better than
58.23% of 735 companies
in the Biotechnology industry
Industry Median: 59.4 vs BSP:T1CH34: 67.13

Bio-Techne had a gross margin of 64.78% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Bio-Techne was 0.50% per year.

Bio-Techne Gross Margin % Historical Data

The historical data trend for Bio-Techne's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Techne Gross Margin % Chart

Bio-Techne Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Gross Margin %

Get a 7-Day Free Trial

66.31

65.41

67.97

68.42

67.72

Bio-Techne Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Gross Margin %	Get a 7-Day Free Trial															67.52	68.73	67.93	66.87	64.78

Competitive Comparison of Bio-Techne's Gross Margin %

For the Biotechnology subindustry, Bio-Techne's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio-Techne's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Techne's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Bio-Techne's Gross Margin % falls into.

Bio-Techne Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Bio-Techne's Gross Margin for the fiscal year that ended in Jun. 2023 is calculated as

Gross Margin % (A: Jun. 2023 )	=	Gross Profit (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	3736.5	/	5517.21
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(5517.21 - 1780.759)	/	5517.21
	=	67.72 %

Bio-Techne's Gross Margin for the quarter that ended in Dec. 2023 is calculated as

Gross Margin % (Q: Dec. 2023 )	=	Gross Profit (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	865.2	/	1335.676
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(1335.676 - 470.435)	/	1335.676
	=	64.78 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Bio-Techne (BSP:T1CH34) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Bio-Techne had a gross margin of 64.78% for the quarter that ended in Dec. 2023 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Bio-Techne Gross Margin % Related Terms

Thank you for viewing the detailed overview of Bio-Techne's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Techne (BSP:T1CH34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Techne Corp (BSP:T1CH34) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

TECH:USA TE1:Germany

Address

614 McKinley Place N.E., Minneapolis, MN, USA, 55413

Website

https://www.bio-techne.com

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Bio-Techne (BSP:T1CH34) Headlines

No Headlines